Source: Ohio Department of Health
The Centers for Disease Control and Prevention (CDC) has learned of an interruption in the supply of cycloserine, which is likely to last for at least the next several weeks. Until the supply of drug is restored, it is recommended that patients should not be started on regimens that include cycloserine in order to reserve existing drug for patients who are already receiving it. For patients currently receiving cycloserine and for whom additional drug is completely unavailable, physicians will need to determine if another second-line drug should be substituted for the duration of the supply interruption. The U.S. Food and Drug Administration will publish information on the status of this interruption, and where to obtain cycloserine once it becomes available on its website.
- Southeastern National TB Center in Gainesville, FL: 800.482.4636
- Curry International TB Center in Oakland, CA: 877.390.6682
- Global TB Institute in Newark, NJ: 800.482.3627
- Heartland National TB Center in San Antonio, TX: 800.839.5864.